Platelet-derived growth factor increases prostaglandin production and decreases epidermal growth factor receptors in human osteosarcoma cells
- 1 January 1982
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 30 (4) , 347-353
- https://doi.org/10.1016/0024-3205(82)90571-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Modulation of Epidermal Growth Factor Receptors on 3T3 Cells by Platelet-Derived Growth FactorScience, 1980
- Characterization and Regulation of Receptors for Epidermal Growth Factor in Mouse Calvaria*Endocrinology, 1980
- Cyclooxygenase products of arachidonic acid metabolism by mouse bone in organ cultureBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Homologous and Heterologous Control of Bone Cell Adenosine 3′,5′-Monophosphate Response to Hormones by Parathormone, Prostaglandin E2, Calcitonin, and 1,25-hydroxycholecalciferol*Endocrinology, 1980
- Stimulation of prostaglandin production in bone by phorbol diesters and melittinProstaglandins, 1978
- Epidermal growth factor stimulates prostaglandin biosynthesis by canine kidney (MDCK) cellsBiochemical and Biophysical Research Communications, 1977
- 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.The Journal of cell biology, 1976
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2The Journal of Experimental Medicine, 1972
- Epidermal Growth Factor and a New DerivativePublished by Elsevier ,1972
- Prostaglandins: Stimulation of Bone Resorption in Tissue CultureEndocrinology, 1970